4-methoxyamphetamine has been researched along with Carcinoma, Squamous Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, L; Garcez, K; Lee, LW; Slevin, N; Sykes, A; Thomson, D | 1 |
| Bennion, NR; Bhirud, AR; Denniston, KA; Gharzai, L; Lin, C; Verma, V | 1 |
| Amemiya, Y; Hasegawa, J; Noguchi, I; Seto, K | 1 |
3 other study(ies) available for 4-methoxyamphetamine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Ninety Day Mortality After Radical Radiotherapy for Head and Neck Cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Death; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis | 2017 |
Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Death; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagus; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Survival Analysis; Survivors | 2016 |
Postoperative death of a patient in apparent remission of malignant lymphoma after dissection for squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Death; Disseminated Intravascular Coagulation; Humans; Immunocompromised Host; Immunosuppression Therapy; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Multiple Organ Failure; Neoplasms, Second Primary; Postoperative Complications; Recurrence; Remission Induction | 1992 |